4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001415889-25-003293
Chief Financial Officer bought 6,000 shares at $5.65 ($33,900)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Young James Emmett Chief Financial Officer | 2025-02-05 | Purchase | +6,000 | $5.65 | $33,900 | 30,000 | I |
| Open-market purchases · 6,000 sh · avg $5.65 · $33,900 | |||||||
Loading xslF345X05/form4-02062025_110257.xml…